2SFDA(国家食品药品监督管理局).Management Rules for Selective Examination of Drug Quality [Z]. GuoShiYaoJianShi [2006]379 (药品质量抽查检验管理规定[Z].国食药监市[2006]379号),2006.
3SFDA(国家食品药品监督管理局).The Guideline of marketed drug sampling and testing for further quality evaluation. GuoShiYaoJianbanji[2009]30(药品评价抽验质量分析指导原则).(国食药监办稽[2009]30号).
4SFDA(国家食品药品监督管理局).2008 national drug sampling and testing plan GuoShiYaoJianShi[2008]21(2008年国家药品抽验工作计划)(国食药监市[2008]21号).
52008 Medicine Quality Analysis Report (2008年国家药品质量分析报告),2008.
7EDWARD D,FROHLICH M D, MAC P. Generic drugs: the good, the bad, and the unknown [ J ]. Ochsner J,2011, 11(2) :98.
8WISOFF T , SELMER R M, HALVORSENO S, et al. Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis [ J ]. BMC Cardiovasc Disord, 2012, 12 (26) : in press.
9AMIDON K S, LANGGUTH P, LENNERNAS H, et al. Bioequivalence of oral products and the biopharmaceutics lassification system: science, regulation, and public policy [ J ]. Clin Pharmacol Ther,2011,90 ( 3 ) : 467-470.
10OM A, LAWRENCE X Y, DALE P,et al. Dissolution tes- ting for generic drugs: An FDA perspective [ J]. AAPS J, 2011,13 (3) :328-335.
